Eculizumab as a therapeutic option in patients with scleroderma renal crisis associated with haemolytic uraemic syndrome

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Translated title of the contribution	Eculizumab as a therapeutic option in patients with scleroderma renal crisis associated with haemolytic uraemic syndrome
Original language	Undefined/Unknown
Pages (from-to)	205-209
Number of pages	4
Journal	Revista Colombiana de Reumatología
State	Published - 1 Jul 2020

Article Classification

@article{e4571cd05892403ea1a16e3b3f95ad9d,

title = "Eculizumab as a therapeutic option in patients with scleroderma renal crisis associated with haemolytic uraemic syndrome",

author = "\{Mora Alfonso\}, \{Sergio Alexander\} and \{Miranda Bucheli\}, Alfredo and \{Saldarriaga Rivera\}, \{Lina Mar{\'i}a\}",

year = "2020",

month = jul,

day = "1",

language = "Indefinido/desconocido",

pages = "205--209",

journal = "Revista Colombiana de Reumatolog{\'i}a",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

}

Eculizumab as a therapeutic option in patients with scleroderma renal crisis associated with haemolytic uraemic syndrome. / Mora Alfonso, Sergio Alexander (Second Author); Miranda Bucheli, Alfredo (First Author); Saldarriaga Rivera, Lina María (Third Author).
In: Revista Colombiana de Reumatología, 01.07.2020, p. 205-209.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Eculizumab as a therapeutic option in patients with scleroderma renal crisis associated with haemolytic uraemic syndrome

AU - Mora Alfonso, Sergio Alexander

AU - Miranda Bucheli, Alfredo

AU - Saldarriaga Rivera, Lina María

PY - 2020/7/1

Y1 - 2020/7/1

M3 - Artículo

SN - 0121-8123

SP - 205

EP - 209

JO - Revista Colombiana de Reumatología

JF - Revista Colombiana de Reumatología

ER -